FLOT2 is overexpressed and correlated with significantly worse prognosis in a variety of types of malignant tumors, including breast cancer, melanoma, stomach cancer, cervical cancer and nasopharyngeal cancer (Liu et al. 2015; Zhao et al. 2015). This evidence concerns the gene FLOT2 and cancer.